260 related articles for article (PubMed ID: 10069538)
1. The in vitro post-antifungal effect of nystatin on Candida species of oral origin.
Ellepola AN; Samaranayake LP
J Oral Pathol Med; 1999 Mar; 28(3):112-6. PubMed ID: 10069538
[TBL] [Abstract][Full Text] [Related]
2. Amphotericin B-induced in vitro postantifungal effect on Candida species of oral origin.
Ellepola AN
Med Princ Pract; 2012; 21(5):442-6. PubMed ID: 22678101
[TBL] [Abstract][Full Text] [Related]
3. Sub-therapeutic exposure to polyene antimycotics elicits a post-antifungal effect (PAFE) and depresses the cell surface hydrophobicity of oral Candida albicans isolates.
Egusa H; Ellepola AN; Nikawa H; Hamada T; Samaranayake LP
J Oral Pathol Med; 2000 May; 29(5):206-13. PubMed ID: 10801037
[TBL] [Abstract][Full Text] [Related]
4. The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion.
Ellepola AN; Samaranayake LP
Oral Dis; 1998 Dec; 4(4):260-7. PubMed ID: 10200705
[TBL] [Abstract][Full Text] [Related]
5. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
Anil S; Ellepola AN; Samaranayake LP
J Oral Pathol Med; 2001 Sep; 30(8):481-8. PubMed ID: 11545239
[TBL] [Abstract][Full Text] [Related]
6. The postantifungal effect of nystatin and its impact on adhesion attributes of oral Candida dubliniensis isolates.
Ellepola AN; Joseph BK; Chandy R; Khan ZU
Mycoses; 2014 Jan; 57(1):56-63. PubMed ID: 23773155
[TBL] [Abstract][Full Text] [Related]
7. Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study.
de Castro RD; de Souza TM; Bezerra LM; Ferreira GL; Costa EM; Cavalcanti AL
BMC Complement Altern Med; 2015 Nov; 15():417. PubMed ID: 26601661
[TBL] [Abstract][Full Text] [Related]
8. Adhesion of oral Candida species to human buccal epithelial cells following brief exposure to nystatin.
Ellepola AN; Panagoda GJ; Samaranayake LP
Oral Microbiol Immunol; 1999 Dec; 14(6):358-63. PubMed ID: 10895691
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of thymoquinone and nystatin in the treatment of oral candidiasis; an in vitro study.
Özdal Zincir Ö; Özdal U; Ünlü Ö; Demirci M; Katiboğlu AB; Egil E; Altan Şallı G
Odontology; 2022 Apr; 110(2):330-337. PubMed ID: 34657217
[TBL] [Abstract][Full Text] [Related]
10. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Post-Antifungal Effect of Rezafungin and Micafungin against Candida albicans, Candida parapsilosis and Candida glabrata.
Carvalhaes CG; Rhomberg PR; Pfaller MA; Locke JB; Castanheira M
Mycoses; 2022 Nov; 65(11):1040-1044. PubMed ID: 35778886
[TBL] [Abstract][Full Text] [Related]
12. Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans.
Ellepola AN; Khajah R; Jayatilake S; Samaranayake L; Sharma P; Khan Z
J Appl Oral Sci; 2015; 23(4):412-8. PubMed ID: 26398514
[TBL] [Abstract][Full Text] [Related]
13. Antifungal Activity of Capric Acid, Nystatin, and Fluconazole and Their
Khalandi H; Masoori L; Farahyar S; Delbandi AA; Raiesi O; Farzanegan A; Khalandi G; Mahmoudi S; Erfanirad T; Falahati M
Assay Drug Dev Technol; 2020; 18(4):195-201. PubMed ID: 32392426
[TBL] [Abstract][Full Text] [Related]
14. Caspofungin-induced in-vitro post-antifungal effect and its impact on adhesion related traits of oral Candida dubliniensis and Candida albicans isolates.
Ellepola AN; Chandy R; Khan ZU; Samaranayake LP
Microbiol Immunol; 2016 Mar; 60(3):160-7. PubMed ID: 26850765
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
Choukri F; Benderdouche M; Sednaoui P
J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
[TBL] [Abstract][Full Text] [Related]
16. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis.
Miranda-Cadena K; Marcos-Arias C; Mateo E; Aguirre JM; Quindós G; Eraso E
Arch Oral Biol; 2018 Nov; 95():100-107. PubMed ID: 30096698
[TBL] [Abstract][Full Text] [Related]
19. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
20. Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility.
Bulacio L; Paz M; Ramadán S; Ramos L; Pairoba C; Sortino M; Escovich L; López C
J Mycol Med; 2012 Dec; 22(4):348-53. PubMed ID: 23518170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
